Top videos
De Quervain's tenosynovitis (dih-kwer-VAINS ten-oh-sine-oh-VIE-tis) is a painful condition affecting the tendons on the thumb side of your wrist. If you have de Quervain's tenosynovitis, it will probably hurt when you turn your wrist, grasp anything or make a fist. Although the exact cause of de Quervain's tenosynovitis isn't known, any activity that relies on repetitive hand or wrist movement — such as working in the garden, playing golf or racket sports, or lifting your baby — can make it worse. Symptoms ShareTweet June 13, 2015 References Products and Services Mayo Clinic Sports Medicine Newsletter: Mayo Clinic Health Letter See also Prednisone risks, benefits Prednisone withdrawal: Why taper down slowly? Integrative approaches to treating pain Lifestyle strategies for pain management Nutrition and pain Pain rehabilitation Self-care approaches to treating pain Show more Advertisement Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission. Advertising & Sponsorship PolicyOpportunitiesAd Choices Mayo Clinic Store Check out these best-sellers and special offers on books and newsletters from Mayo Clinic. NEW! – The Mayo Clinic Diet, Second Edition Healthy Heart for Life! Mayo Clinic on Better Hearing and Balance Treatment Strategies for Arthritis The Mayo Clinic Diet Online
The goal of COPD management is to improve a patient’s functional status and quality of life by preserving optimal lung function, improving symptoms, and preventing the recurrence of exacerbations. Currently, no treatments aside from lung transplantation have been shown to significantly improve lung function or decrease mortality; however, oxygen therapy (when appropriate) and smoking cessation may reduce mortality. Once the diagnosis of COPD is established, it is important to educate the patient about the disease and to encourage his or her active participation in therapy.
Dialysis services at UC San Diego Health: https://health.ucsd.edu/care/kidney/dialysis
UC San Diego Health Licensed Clinical Social Worker, Norma Reggev, discusses hemodialysis as a treatment option for failing kidneys with patient testimonials. Discussion includes In Center Hemodialysis and Home Hemodialysis.
0:00 - Hemodialysis
1:34 - When Should Dialysis Begin?
2:00 - What is Dialysis?
2:25 - How Hemodialysis Works
3:15 - In-Center Hemodialysis Considerations
3:42 - Patient Shares Their Experience With In-Center Hemodialysis
7:30 - Home Hemodialysis Considerations
8:35 - Patient Shares Their Experience With Home Hemodialysis
12:23 - Types of Vascular Access
Personality disorders are a group of mental illnesses. They involve long-term patterns of thoughts and behaviors that are unhealthy and inflexible. The behaviors cause serious problems with relationships and work. People with personality disorders have trouble dealing with everyday stresses and problems. They often have stormy relationships with other people. The cause of personality disorders is unknown. However, genes and childhood experiences may play a role. The symptoms of each personality disorder are different. They can mild or severe. People with personality disorders may have trouble realizing that they have a problem. To them, their thoughts are normal, and they often blame others for their problems. They may try to get help because of their problems with relationships and work. Treatment usually includes talk therapy and sometimes medicine.
A C-reactive protein (CRP) test is a blood test that measures the amount of a protein called C-reactive protein in your blood. C-reactive protein measures general levels of inflammation in your body. High levels of CRP are caused by infections and many long-term diseases.
Uncomplicated acute otitis media (AOM) should be treated empirically with amoxicillin. Recurrent AOM should raise concern for beta-lactamase resistance and warrants treatment with amoxicillin-clavulanic acid. Ototopical medications are unnecessary, even if there is tympanic membrane perforation.
Cytomegalovirus (CMV) continues to have a tremendous impact in solid organ transplantation despite remarkable advances in its diagnosis, prevention and treatment. It can affect allograft function and increase patient morbidity and mortality through a number of direct and indirect effects. Patients may develop asymptomatic viremia, CMV syndrome or tissue-invasive disease. Late-onset CMV disease continues to be a major problem in high-risk patients after completion of antiviral prophylaxis. Emerging data suggests that immunologic monitoring may be useful in predicting the risk of late onset CMV disease. There is now increasing interest in the development of an effective vaccine for prevention. Novel antiviral drugs with unique mechanisms of action and lesser toxicity are being developed. Viral load quantification is now undergoing standardization, and this will permit the generation of clinically relevant viral thresholds for the management of patients. This article provides a brief overview of the contemporary epidemiology, clinical presentation, diagnosis, prevention and treatment of CMV infection in solid organ transplant recipients.
IVC filter is placed to prevent fatal Pulmonary Embolism due to Deep Venous Thrombosis (DVT). This particular patient had extensive DVT of Ilio-Femoral veins leading to massive swelling of left lower limb. The IVC filter was inserted via the Right Femoral Vein. This case was the first IVC filter placement of North Bengal and adjoining areas.